Glutamine deprivation increases expression and binding of BIM to BCL-286,87, thereby sensitizing MM cells to venetoclax, while metabolic supplementation with α-ketoglutarate reverses this sensitivity87. This evidence concerns the gene BCL2L11 and Miyoshi myopathy.